Literature DB >> 24764562

Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.

Pontus Lundberg1, Ronny Nienhold, Achille Ambrosetti, Francisco Cervantes, Manuel M Pérez-Encinas, Radek C Skoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24764562     DOI： 10.1182/blood-2014-01-550863

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Germline RBBP6 mutations in familial myeloproliferative neoplasms.

Authors:  Ashot S Harutyunyan; Roberto Giambruno; Christian Krendl; Alexey Stukalov; Thorsten Klampfl; Tiina Berg; Doris Chen; Jelena D Milosevic Feenstra; Roland Jäger; Bettina Gisslinger; Heinz Gisslinger; Elisa Rumi; Francesco Passamonti; Daniela Pietra; André C Müller; Katja Parapatics; Florian P Breitwieser; Richard Herrmann; Jacques Colinge; Keiryn L Bennett; Giulio Superti-Furga; Mario Cazzola; Emma Hammond; Robert Kralovics
Journal:  Blood       Date:  2015-11-16       Impact factor: 22.113

Review 2.  Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).

Authors:  Wenyi Luo; Zhongxin Yu
Journal:  Stem Cell Investig       Date:  2015-08-31

3.  Survival in patients with familial and sporadic myeloproliferative neoplasms.

Authors:  Malin Hultcrantz; Sigrún H Lund; Ola Landgren; Jan Samuelsson; Lynn R Goldin; Asmundur Oddsson; Magnus Björkholm; Sigurdur Y Kristinsson
Journal:  Blood       Date:  2015-06-04       Impact factor: 22.113

4.  CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Authors:  Yi Chen; Yang Zhang; Zhihua Wang; Yewei Wang; Yujiao Luo; Nannan Sun; Shasha Zheng; Wenzhe Yan; Xiang Xiao; Sufang Liu; Ji Li; Hongling Peng; Yunxiao Xu; Guoyu Hu; Zhao Cheng; Guangsen Zhang
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

Review 5.  Back to biology: new insights on inheritance in myeloproliferative disorders.

Authors:  Evan M Braunstein; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

6.  Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function.

Authors:  Lilian Varricchio; Mario Falchi; Massimiliano Dall'Ora; Caterina De Benedittis; Alessandra Ruggeri; Vladimir N Uversky; Anna Rita Migliaccio
Journal:  Front Cell Dev Biol       Date:  2017-11-23

7.  Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.

Authors:  Lise Secardin; Cintia Gomez Limia; Suzana da Silva-Benedito; Larissa Lordier; Mira El-Khoury; Caroline Marty; Jean-Christophe Ianotto; Hana Raslova; Stefan N Constantinescu; Martín Hernán Bonamino; William Vainchenker; Barbara Monte-Mor; Antonio Di Stefano; Isabelle Plo
Journal:  Hemasphere       Date:  2021-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.